Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.
Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.
Korean J Pediatr. 2018 Feb;61(2):53-58
Authors: Kim C, Choi YB, Lee JW, Yoo KH, Sung KW, Koo HH
Abstract Purpose: Although the prognosis is generally good in patients with intermediate-risk neuroblastoma, no consensus has been reached on the ideal treatment regimen.